1 - 17 of about 17
English: Miki Takahara, Tomoaki Sabusawa, Kenzo Ohara, Akihiro Katada, Tatsuya Hayashi, Yasuaki Harabuchi, Treatment outcomes of sialendoscopy for submandibular gland sialolithiasis , Auris Nasus Larynx , 2023
English: Kenzo Ohara, Miki Takahara, Takumi Kumai, Masaaki Yamashina, Kan Kishibe, Akihiro Katada, Tatsuya Hayashi , Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study , Braz J Otorhinolaryngol. , 2022 , (IF:2.2)
English: Kenzo Ohara, Akihiro Katada, Takumi Kumai, Hisataka Ominato, Yui Hirata-Nozaki, Tomoaki Sabusawa, Hidekiyo Yamaki, Michihisa Kono, Hiroki Komatsudaa, Risa Wakisaka, Miki Takahara, Tatsuya Hayashia, Yasuaki Harabuchia, Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous fistula: A case report and retrospective analysis of 12 cases , Auris Nasus Larynx , 2022 , (IF:1.863)
English: Michihisa Kono, Hidekiyo Yamaki, Hiroki Komatsuda, Takumi Kumai, Ryusuke Hayashi, Risa Wakisaka, Ryosuke Sato, Kenzo Ohara, Kan Kishibe, Miki Takahara, Akihiro Katada, Tatsuya Hayashi, Yasuaki Harabuchi , IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer , Trans Oncology. , 2022
English: Koji Iijima, Takao Kobayashi, Koji Matsumoto, Kenzo Ohara, Hirohito Kita, Li Y. Drake, Transient IL-33 upregulation in neonatal mouse lung promotes acute but not chronic type 2 immune responses induced by allergen later in life , PLOS ONE , 2021 , (IF:3.73)
English: Hayashi R, Nagato T, Kumai T, Ohara K, Oharad M, Ohkuria T, Hirata-Nozakib Y, Harabuchi S, Kosaka A, Nagata M, Yajima Y, Yasuda S, Oikawa K, Kono M, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Harabuchib Y, Kobayashia H, Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma , Oncoimmunology , vol.10 (1) , 2020
English: Ohara M, Ohara K, Kumai T, Ohkuri T, Nagato T, Hirata-Nozaki Y, Kosaka A, Nagata M, Hayashi R, Harabuchi S, Yajima Y, Oikawa K, Harabuchi Y, Furukawa H, Kobayashi H, Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer. , Cancer Immunology Immunotherapy , vol.69 (6) (p.989 - 999) , 2020
English: Harabuchi S, Kosaka M, Yajima Y, Nagata M, Hayashi R, Kumai T, Ohara K, Nagato T, Oikawa K, Ohara M, Harabuchi Y, Ohkuri T, Kobayashi H, Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma , Biochemical and Biophysical Research Communications , 2019
English: Hirata-Nozaki Y, Ohkuri T, Ohara K, Kumai T, Nagata M, Harabuchi S, Kosaka A, Nagato T, Ishibashi K, Oikawa K, Aoki N, Ohara M, Harabuchi Y, Uno Y, Takei H, Celis E, Kobayashi H, PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma , Journal of Translational Medicine , vol.17 , 2019
English: Nagato T, Ueda S, Takahara M, Kishibe K, Komabayashi Y, Kumai T, Ohara K, Hirata-Nozaki Y, Harabuchi S, Hayashi R, Ohkuri T, Bernasconi M, Nadal D, Kobayashi H, Harabuchi Y, Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma , Laboratory Investigation , 2019
English: Ohara K, Ohkuri T, Kumai T.(Corresponding), Nagato T.Nozaki Y, Ishibashi K, Kosaka A, Nagata M, Harabuchi S, Ohara M, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H, Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma , OncoImmunology , vol.7 , 2018
English: Uehara J, Ohkuri T, Kosaka A, Ishibashi K, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Ishida-Yamamoto A, Kobayashi H, Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb , Biochem Biophys Res Commun , vol.490 (p.521 - 527) , 2017
English: Nagato T, Ohkuri T, Ohara K, Hirata Y, Kishibe K, Komabayashi Y, Ueda S, Takahara M, Kumai T, Ishibashi K, Kosaka A, Aoki N, Oikawa K, Uno Y, Akiyama N, Sado M, Takei H, Celis E, Harabuchi Y, Kobayashi H, Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy , Cancer Immunol Immunother , vol.66 (p.877 - 890) , 2017
English: Ohkuri T, Kosaka A, Ishibashi K, Kumai T, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H, Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site , Cancer Immunol Immunother , vol.66 (p.705 - 716) , 2017
English: Kumai T, Ishibashi K(co-firstauthor),Ohkuri T,Kosaka A, Nagato T, Hirata Y, Ohara K, Oikawa K, Aoki N, Akiyama N, Sado M, Kitada M, Harabuchi Y, Celis E, Kobayashi H, Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy , Oncoimmunology , 2016
English: Nagato T, Ohara K, Takahara M, Hayashi T, Harabuchi Y, images: Eagle's syndrome , Arthritis Rheum , vol.64 (5) (p.1561 - ) , 2012 , (IF:7.332)
English: Hayashi T, Yoshizaki T, Ohara K, Yoshida S, Kumai T, Harabuchi Y, Recent changes in nasopharyngeal flora of children in Japan. , Adv Otorhinolaryngol , vol.72 (p.176 - 178) , 2011
Page: [<<PREV] [1] [NEXT>>]
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.